Jupitavir 150 mg+100 mg (Nirmatrelvir + Ritonavir)

Composition

Each combipack contains-

4 Nirmatrelvir Tablets (each tablet contains Nirmatrelvir INN 150 mg) and

2 Ritonavir Tablets (each tablet contains Ritonavir USP 100 mg)

Indications

Indicated for mild-to-moderate COVID-19 positive adult and pediatric patients (12 years of age and older weighing at least 40 kg), who are at high risk for progression to severe COVID-19, including hospitalization or death.

Dosage & Administration

Nirmatrelvir must be co-administered with Ritonavir. Initiate this treatment as soon as possible after diagnosis of COVID-19 and within 3-5 days of symptom onset. Administer orally with or without food.

Dosage: 300 mg Nirmatrelvir (two 150 mg tablets) with 100 mg Ritonavir (one 100 mg tablet), with all three tablets taken together twice daily for 5 days.